News
Q2 2025 Earnings Call Transcript August 14, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-3 ...
Gross margin contracted to 35.6% in fiscal Q3 2025 (period ended June 30, 2025), down from 53.4% a year earlier, due to "lower than anticipated gross margins received fromHoneywell(NASDAQ: HON) on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback